State Street
MIST icon

State Street’s Milestone Pharmaceuticals MIST Stock Holding History

State Street’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$26.6K Buy
22,331
+456
+2% +$798 ﹤0.01% 4195
2025
Q4 		$44.2K Sell
21,875
-345
-2% -$743 ﹤0.01% 4173
2025
Q3 		$44.4K Buy
22,220
+3,974
+22% +$6.99K ﹤0.01% 4171
2025
Q2 		$35.4K Sell
18,246
-291
-2% -$388 ﹤0.01% 4142
2025
Q1 		$14.8K Sell
18,537
-580
-3% -$1.15K ﹤0.01% 4232
2024
Q4 		$45.1K Sell
19,117
-194
-1% -$333 ﹤0.01% 4118
2024
Q3 		$29.4K Buy
19,311
+388
+2% +$565 ﹤0.01% 4180
2024
Q2 		$25.2K Hold
18,923
– – ﹤0.01% 4253
2024
Q1 		$33.9K Sell
18,923
-2,688
-12% -$4.37K ﹤0.01% 4223
2023
Q4 		$36.1K Hold
21,611
– – ﹤0.01% 4256
2023
Q3 		$67K Hold
21,611
– – ﹤0.01% 4209
2023
Q2 		$61.6K Sell
21,611
-388
-2% -$1.46K ﹤0.01% 4366
2023
Q1 		$86.7K Sell
21,999
-94
-0.4% -$344 ﹤0.01% 4362
2022
Q4 		$87.5K Buy
22,093
+97
+0.4% +$511 ﹤0.01% 4410
2022
Q3 		$202K Buy
21,996
+388
+2% +$2.94K ﹤0.01% 4141
2022
Q2 		$128K Sell
21,608
-194
-0.9% -$1.19K ﹤0.01% 4405
2022
Q1 		$140K Buy
21,802
+970
+5% +$6.06K ﹤0.01% 4520
2021
Q4 		$136K Buy
20,832
+384
+2% +$2.3K ﹤0.01% 4496
2021
Q3 		$117K Buy
20,448
+3,822
+23% +$21.5K ﹤0.01% 4506
2021
Q2 		$91K Sell
16,626
-390
-2% -$2.21K ﹤0.01% 4377
2021
Q1 		$99K Hold
17,016
– – ﹤0.01% 3902
2020
Q4 		$114K Sell
17,016
-546
-3% -$3.66K ﹤0.01% 3802
2020
Q3 		$129K Buy
+17,562
New +$126K ﹤0.01% 3696

Other funds holding MIST

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

State Street's MIST Position: Q1 2026 in Review

State Street increased its Milestone Pharmaceuticals (MIST) stake by 2.1% in Q1 2026, buying an estimated $798 and bringing the position to 22,331 shares worth $26.6K. The position accounts for ﹤0.01% of the portfolio, ranked #4195.

State Street first reported a position in MIST in Q3 2020 and has held it in 23 quarters since. The position peaked at $202K in Q3 2022. 86 funds tracked by Wall St. Rank hold MIST as of Q1 2026.

  • State Street held 22,331 shares of Milestone Pharmaceuticals worth $26.6K as of Q1 2026.
  • State Street bought 456 Milestone Pharmaceuticals shares in Q1 2026, an estimated $798.
  • Milestone Pharmaceuticals made up ﹤0.01% of State Street's portfolio in Q1 2026, its #4195 holding.
  • State Street first reported a position in Milestone Pharmaceuticals in Q3 2020 and has held it in 23 quarters since.
  • State Street's Milestone Pharmaceuticals position peaked at $202K in Q3 2022.
  • 86 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q1 2026.

Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.